Filing excerpt
our ability to expand our business beyond oncology into new disease areas;
A key growth initiative for Tempus is to apply its data and AI platform to new disease areas, with neurology and cardiology already in progress. This expansion requires investment in new data acquisition, domain-specific expertise, and go-to-market efforts for these new verticals.
Filing excerpt
our ability to expand our business beyond oncology into new disease areas;
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
sec-10kmarketExpansionGet every 10-K signal for Tempus AI and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Tempus AI this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/1f4c9108-3e75-4dda-b7b9-d5c1b435bdf7 returns this record as JSON. POST /v1/companies/enrich returns every signal for tempus.com.
{
"signal_id": "1f4c9108-3e75-4dda-b7b9-d5c1b435bdf7",
"signal_type": "sec-10k",
"signal_subtype": "marketExpansion",
"detected_at": "2026-03-03T06:07:15.511+00:00",
"company": {
"name": "Tempus AI",
"domain": "tempus.com"
},
"data": {
"detail": "A key growth initiative for Tempus is to apply its data and AI platform to new disease areas, with neurology and cardiology already in progress. This expansion requires investment in new data acquisition, domain-specific expertise, and go-to-market efforts for these new verticals.",
"summary": "Tempus is strategically expanding beyond oncology into neurology and cardiology.",
"excerpts": "our ability to expand our business beyond oncology into new disease areas;",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1717115/000119312526066961/tem-20251231.htm",
"filing_date": "2026-02-24",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Scaling infrastructure needed",
"signal_category": "market",
"technologies_mentioned": [
"AI"
]
}
}
curl https://signals.autobound.ai/v1/signals/1f4c9108-3e75-4dda-b7b9-d5c1b435bdf7 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"tempus.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.